Advertisement
ADUS vs CHE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADUS is a Hold and CHE is a Buy.
ADUS in upward trend: price rose above 50-day moving average on October 20, 2026
ADUS moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 44 of 56 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on ADUS as a result. In 54 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
The Moving Average Convergence Divergence (MACD) for ADUS just turned positive on October 08, 2026. Looking at past instances where ADUS's MACD turned positive, the stock continued to rise in 24 of 46 cases over the following month. The odds of a continued upward trend are 52%.
The 10-day moving average for ADUS crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 70%.
Following a +1.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where ADUS advanced for three days, in 202 of 310 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Aroon Indicator entered an Uptrend today. In 142 of 218 cases where ADUS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
ADUS broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 39 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. ADUS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.063) is normal, around the industry mean (203.977). P/E Ratio (21.864) is within average values for comparable stocks, (20.904). Projected Growth (PEG Ratio) (0.983) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.097) among similar stocks. P/S Ratio (1.483) is also within normal values, averaging (2.688).
The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CHE in upward trend: 10-day moving average moved above 50-day moving average on October 28, 2026
The 10-day moving average for CHE crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on CHE as a result. In 50 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.
The Moving Average Convergence Divergence (MACD) for CHE just turned positive on October 14, 2026. Looking at past instances where CHE's MACD turned positive, the stock continued to rise in 28 of 51 cases over the following month. The odds of a continued upward trend are 55%.
CHE moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +6.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHE advanced for three days, in 159 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.
The Aroon Indicator entered an Uptrend today. In 75 of 200 cases where CHE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 38%.
Bearish Trend Analysis
The 10-day RSI Indicator for CHE moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 25 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 64%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 68 cases where CHE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.
CHE broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 36 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. CHE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 67 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock better than average.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.400) is normal, around the industry mean (203.977). P/E Ratio (26.836) is within average values for comparable stocks, (20.904). Projected Growth (PEG Ratio) (1.876) is also within normal values, averaging (2.498). Dividend Yield (0.005) settles around the average of (0.097) among similar stocks. P/S Ratio (2.714) is also within normal values, averaging (2.688).
ADUS | CHE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 45 | 25 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 72 Overvalued | 80 Overvalued | |
PROFIT vs RISK RATING 1..100 | 39 | 67 | |
SMR RATING 1..100 | 72 | 36 | |
PRICE GROWTH RATING 1..100 | 41 | 43 | |
P/E GROWTH RATING 1..100 | 65 | 27 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ADUS's Valuation (72) in the Medical Or Nursing Services industry is in the same range as CHE (80). This means that ADUS’s stock grew similarly to CHE’s over the last 12 months.
ADUS's Profit vs Risk Rating (39) in the Medical Or Nursing Services industry is in the same range as CHE (67). This means that ADUS’s stock grew similarly to CHE’s over the last 12 months.
CHE's SMR Rating (36) in the Medical Or Nursing Services industry is somewhat better than the same rating for ADUS (72). This means that CHE’s stock grew somewhat faster than ADUS’s over the last 12 months.
ADUS's Price Growth Rating (41) in the Medical Or Nursing Services industry is in the same range as CHE (43). This means that ADUS’s stock grew similarly to CHE’s over the last 12 months.
CHE's P/E Growth Rating (27) in the Medical Or Nursing Services industry is somewhat better than the same rating for ADUS (65). This means that CHE’s stock grew somewhat faster than ADUS’s over the last 12 months.
| ADUS | CHE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 67% | 2 days ago 64% |
| Stochastic ODDS (%) | 2 days ago 59% | 2 days ago 53% |
| Momentum ODDS (%) | 2 days ago 64% | 2 days ago 55% |
| MACD ODDS (%) | 2 days ago 52% | 2 days ago 55% |
| TrendWeek ODDS (%) | 2 days ago 67% | 2 days ago 49% |
| TrendMonth ODDS (%) | 2 days ago 64% | 2 days ago 52% |
| Advances ODDS (%) | 3 days ago 65% | 9 days ago 49% |
| Declines ODDS (%) | 12 days ago 63% | 11 days ago 49% |
| BollingerBands ODDS (%) | 2 days ago 64% | 2 days ago 48% |
| Aroon ODDS (%) | 2 days ago 65% | 2 days ago 38% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ADUS’s FA Score shows that 0 FA rating(s) are green while CHE’s FA Score has 1 green FA rating(s).
- ADUS’s FA Score: 0 green, 5 red.
- CHE’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ADUS’s TA Score shows that 6 TA indicator(s) are bullish while CHE’s TA Score has 6 bullish TA indicator(s).
- ADUS’s TA Score: 6 bullish, 4 bearish.
- CHE’s TA Score: 6 bullish, 4 bearish.
Price Growth
ADUS (@Hospital/Nursing Management) experienced а +1.99% price change this week, while CHE (@Hospital/Nursing Management) price change was -1.50% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -2.17%. For the same industry, the average monthly price growth was +2.39%, and the average quarterly price growth was +11.91%.
Reported Earning Dates
ADUS is expected to report earnings on Mar 01, 2027.
CHE is expected to report earnings on Feb 25, 2027.
Industries' Descriptions
@Hospital/Nursing Management (-2.17% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
ADUS and
Correlation & Price change
A.I.dvisor indicates that over the last year, ADUS has been loosely correlated with PNTG. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ADUS jumps, then PNTG could also see price increases.
| Ticker / NAME | Correlation To ADUS | 1D Price Change % | ||
|---|---|---|---|---|
| ADUS | 100% | -0.88% | ||
| PNTG - ADUS | 41% Loosely correlated | -9.17% | ||
| CHE - ADUS | 37% Loosely correlated | -2.71% | ||
| NHC - ADUS | 36% Loosely correlated | -2.25% | ||
| HCSG - ADUS | 36% Loosely correlated | -5.39% | ||
| ENSG - ADUS | 36% Loosely correlated | -3.14% | ||
More | ||||
CHE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CHE has been loosely correlated with UHS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CHE jumps, then UHS could also see price increases.
| Ticker / NAME | Correlation To CHE | 1D Price Change % | ||
|---|---|---|---|---|
| CHE | 100% | -2.71% | ||
| UHS - CHE | 43% Loosely correlated | +1.08% | ||
| ENSG - CHE | 40% Loosely correlated | -3.14% | ||
| PNTG - CHE | 33% Poorly correlated | -9.17% | ||
| OPCH - CHE | 32% Poorly correlated | -0.47% | ||
| NHC - CHE | 25% Poorly correlated | -2.25% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DSM | 5.55 | -0.05 | -0.89% |
| BNY Mellon Strategic Municipal | |||
| FINY | 24.97 | -0.23 | -0.90% |
| GraniteShares YieldBOOST Financials ETF (FINY) | |||
| EWA | 29.25 | -0.61 | -2.04% |
| iShares MSCI Australia ETF (EWA) | |||
| UMAY | 38.16 | -0.89 | -2.27% |
| Innovator U.S. Equity Ultra Buffer ETF - May (UMAY) | |||
| ENHI | 26.26 | -0.79 | -2.94% |
| iShares Enhanced International Active ETF (ENHI) | |||